Similar articles for PMID: 18193704

Year	Number of Results
1983	1
1985	2
1986	1
1988	1
1989	1
1990	2
1991	3
1992	3
1993	2
1994	6
1995	3
1996	2
1997	4
1998	2
1999	1
2000	3
2001	4
2002	6
2003	3
2006	2
2007	4
2009	1
2010	4
2011	9
2012	4
2013	7
2014	7
2015	7
2016	3
2017	2
2018	3
2019	1
2020	2
2021	2
2022	2

1

Science and serendipity.

Pepys MB. Pepys MB. Clin Med (Lond). 2007 Dec;7(6):562-78. doi: 10.7861/clinmedicine.7-6-562. Clin Med (Lond). 2007. PMID: 18193704 Free PMC article. Review.

2

The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs.

Pepys MB. Pepys MB. Front Immunol. 2018 Oct 16;9:2382. doi: 10.3389/fimmu.2018.02382. eCollection 2018. Front Immunol. 2018. PMID: 30459761 Free PMC article. Review.

3

Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro.

Ozawa D, Nomura R, Mangione PP, Hasegawa K, Okoshi T, Porcari R, Bellotti V, Naiki H. Ozawa D, et al. Sci Rep. 2016 Jul 6;6:29077. doi: 10.1038/srep29077. Sci Rep. 2016. PMID: 27380955 Free PMC article.

4

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.

Pepys MB, Herbert J, Hutchinson WL, Tennent GA, Lachmann HJ, Gallimore JR, Lovat LB, Bartfai T, Alanine A, Hertel C, Hoffmann T, Jakob-Roetne R, Norcross RD, Kemp JA, Yamamura K, Suzuki M, Taylor GW, Murray S, Thompson D, Purvis A, Kolstoe S, Wood SP, Hawkins PN. Pepys MB, et al. Nature. 2002 May 16;417(6886):254-9. doi: 10.1038/417254a. Nature. 2002. PMID: 12015594

5

Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis.

Hachulla E, Maulin L, Deveaux M, Facon T, Blétry O, Vanhille P, Wechsler B, Godeau P, Levesque H, Hatron PY, Huglo D, Devulder B, Marchandise X. Hachulla E, et al. Am J Med. 1996 Jul;101(1):77-87. doi: 10.1016/s0002-9343(94)00054-9. Am J Med. 1996. PMID: 8686719

6

Structural basis of ligand specificity in the human pentraxins, C-reactive protein and serum amyloid P component.

Mikolajek H, Kolstoe SE, Pye VE, Mangione P, Pepys MB, Wood SP. Mikolajek H, et al. J Mol Recognit. 2011 Mar-Apr;24(2):371-7. doi: 10.1002/jmr.1090. J Mol Recognit. 2011. PMID: 21360619

7

Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis.

Gillmore JD, Tennent GA, Hutchinson WL, Gallimore JR, Lachmann HJ, Goodman HJ, Offer M, Millar DJ, Petrie A, Hawkins PN, Pepys MB. Gillmore JD, et al. Br J Haematol. 2010 Mar;148(5):760-7. doi: 10.1111/j.1365-2141.2009.08036.x. Epub 2010 Jan 8. Br J Haematol. 2010. PMID: 20064157

8

'Localized amyloidosis': 123I-labelled SAP component scintigraphy and labial salivary gland biopsy.

Maulin L, Hachulla E, Deveaux M, Janin A, Wechsler B, Godeau P, Rousset H, Barrier JH, Hatron PY, Devulder B, Huglo D, Marchandise X. Maulin L, et al. QJM. 1997 Jan;90(1):45-50. doi: 10.1093/qjmed/90.1.45. QJM. 1997. PMID: 9093588

9

Female protein, amyloidosis, and hormonal carcinogenesis in Turkish hamster: differences from Syrian hamster.

Coe JE, Cieplak W, Hadlow WJ, Ross MJ. Coe JE, et al. Am J Physiol. 1997 Sep;273(3 Pt 2):R934-41. doi: 10.1152/ajpregu.1997.273.3.R934. Am J Physiol. 1997. PMID: 9321870

10

Association of plasma pentraxin-3 levels with coronary risk factors and the lipid profile: a cross-sectional study in Japanese patients with stable angina pectoris.

Morishita T, Uzui H, Nakano A, Fukuoka Y, Ikeda H, Amaya N, Kaseno K, Ishida K, Lee JD, Tada H. Morishita T, et al. Heart Vessels. 2018 Nov;33(11):1301-1310. doi: 10.1007/s00380-018-1191-8. Epub 2018 May 22. Heart Vessels. 2018. PMID: 29789902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed